-
公开(公告)号:US20100266696A1
公开(公告)日:2010-10-21
申请号:US12745806
申请日:2008-12-11
申请人: Gerhard Muhrer , Thomas Kieckbusch , Ranjit Thakur , Norbert Rasenack , Dilraj Singh , Kurt Schaffluetzel
发明人: Gerhard Muhrer , Thomas Kieckbusch , Ranjit Thakur , Norbert Rasenack , Dilraj Singh , Kurt Schaffluetzel
CPC分类号: A61K9/145 , A61K9/0075 , A61K9/008 , A61K31/40
摘要: A process of preparing a particulate and substantially crystalline drug substance. The process involves suspending a substantially crystalline drug substance in an anti-solvent to give a suspension, homogenising the suspension at elevated pressure to give drug particles that have a mean particle size of less than about 10 μm, and drying the drug particles to remove any residual anti-solvent.
摘要翻译: 制备颗粒状和基本上结晶的药物物质的方法。 该方法包括将基本上结晶的药物物质悬浮在抗溶剂中以产生悬浮液,在升高的压力下使悬浮液均质化,得到平均粒度小于约10μm的药物颗粒,并干燥药物颗粒以除去任何 残留的抗溶剂。
-
公开(公告)号:US20090203777A1
公开(公告)日:2009-08-13
申请号:US11911391
申请日:2006-04-12
申请人: Henry Luke Danahay , Darren Mark Legrand , David C. Tully , Jennifer Leslie Harris , Silvia Heuerding , Dilraj Singh , Janet Catherine Maas , Juergen Roettele , Jean-Louis Reber , Stephanie Monnier
发明人: Henry Luke Danahay , Darren Mark Legrand , David C. Tully , Jennifer Leslie Harris , Silvia Heuerding , Dilraj Singh , Janet Catherine Maas , Juergen Roettele , Jean-Louis Reber , Stephanie Monnier
IPC分类号: A61K31/235 , C07C279/18
CPC分类号: A61K9/19 , C07C279/18
摘要: The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
摘要翻译: 本发明描述了新的药学上可接受的盐形式的camostat,冻干方法,掩味制剂,雾化制剂以及前述治疗呼吸系统疾病,特别是囊性纤维化和慢性阻塞性肺病(COPD) 。
-
公开(公告)号:US20140152770A1
公开(公告)日:2014-06-05
申请号:US13909997
申请日:2013-06-04
CPC分类号: H04N7/185
摘要: A system for detecting moving objects within a predetermined geographical area is provided. The system is designed to convey object movement information from an airborne surveillance platform to a ground-based operator station with reduced data transmission. This is accomplished by computer processing image data on the surveillance platform prior to transmitting data to the ground station. First, the system constructs a 3D model of the area under surveillance, for example, by obtaining many different views of the area using an aircraft. One 3D model is maintained at the surveillance platform, and another is transmitted to the ground station. During a surveillance mission, a succession of relatively low data, 2D images are created and aligned with the surveillance platform's 3D model. The alignment reveals differences in the images (tracking data) which is then transmitted to the ground station for use with the ground station's 3D model to resolve object movement information.
摘要翻译: 提供了一种用于检测预定地理区域内的移动物体的系统。 该系统旨在将物体运动信息从机载监视平台传送到具有减少的数据传输的地面操作员站。 这是通过在将数据发送到地面站之前在监视平台上计算机处理图像数据来实现的。 首先,系统构建了监视区域的3D模型,例如通过使用飞机获得该区域的许多不同视图。 在监控平台上维护一个3D模型,另一个模型被传输到地面站。 在监视任务期间,一连串相对较低的数据,创建2D图像并与监视平台的3D模型对齐。 对准显示图像(跟踪数据)的差异,然后将其传输到地面站,以便与地面站的3D模型一起使用,以解决物体移动信息。
-
公开(公告)号:US20120208882A1
公开(公告)日:2012-08-16
申请号:US13372984
申请日:2012-02-14
申请人: Henry Luke Danahay , Darren Mark LeGrand , David C. Tully , Jennifer Leslie Harris , Silvia Heuerding , Dilraj Singh , Janet Catherine Maas , Juergen Roettele , Jean-Louis Reber , Stéphanie Monnier
发明人: Henry Luke Danahay , Darren Mark LeGrand , David C. Tully , Jennifer Leslie Harris , Silvia Heuerding , Dilraj Singh , Janet Catherine Maas , Juergen Roettele , Jean-Louis Reber , Stéphanie Monnier
IPC分类号: A61K31/245 , A61P11/00
CPC分类号: A61K9/19 , C07C279/18
摘要: The invention describes novel pharmaceutically acceptable salt forms of camostat, processes for lyophilisation, taste-masked formulations, nebulised formulations and the use of each of the fore-going in the treatment of respiratory diseases, particularly cystic fibrosis and chronic obstructive pulmonary disease (COPD).
摘要翻译: 本发明描述了新的药学上可接受的盐形式的camostat,冻干方法,掩味制剂,雾化制剂以及前述治疗呼吸系统疾病,特别是囊性纤维化和慢性阻塞性肺病(COPD) 。
-
公开(公告)号:US20080216825A1
公开(公告)日:2008-09-11
申请号:US11996981
申请日:2006-08-04
申请人: Dilraj Singh , Gerard Provot
发明人: Dilraj Singh , Gerard Provot
IPC分类号: A61M11/00
CPC分类号: A61M15/009 , A61M2202/064 , A61M2205/0233 , A61M2205/3633 , B65D83/38
摘要: An insulated canister for, pressurized or non-pressurized systems, use with a metered dose system for example, a metered dose inhaler or topical aerosol featuring an inner container surrounded by an outer container with a gap defined by the space between the walls of the inner and outer container. Such gap can be filled by a vacuum, air or material with low thermal conductivity.
摘要翻译: 用于加压或非加压系统的隔热罐用于计量剂量系统,例如计量剂量吸入器或局部气雾剂,其特征在于由外部容器包围的内部容器,所述内部容器具有由内部的壁之间的空间限定的间隙 和外容器。 这样的间隙可以由真空,空气或具有低导热性的材料填充。
-
-
-
-